Ashfield Capital Partners, LLC Abbott Laboratories Transaction History

Ashfield Capital Partners, LLC

$1.19 Billion
Q3 2022

A detailed history of Ashfield Capital Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Ashfield Capital Partners, LLC holds 57,706 shares of ABT stock, worth $6.8 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

57,706

Previous 57,504 0.35%

Holding current value

$6.8 Million

Previous $6.25 Million 10.63%

% of portfolio

0.47%

Previous 0.49%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $19,545 - $22,630	202 Added 0.35%	57,706 $5.58 Million
Q2 2022 Jul 29, 2022	SELL	$102.07 - $123.37 $107,785 - $130,278	-1,056 Reduced 1.8%	57,504 $6.25 Million
Q1 2022 May 11, 2022	SELL	$114.02 - $139.04 $12,770 - $15,572	-112 Reduced 0.19%	58,560 $6.93 Million
Q4 2021 Feb 02, 2022	SELL	$115.53 - $141.46 $3.66 Million - $4.48 Million	-31,697 Reduced 35.08%	58,672 $8.26 Million
Q3 2021 Nov 09, 2021	SELL	$116.66 - $129.06 $144,775 - $160,163	-1,241 Reduced 1.35%	90,369 $10.7 Million
Q2 2021 Aug 09, 2021	SELL	$105.79 - $124.53 $1.04 Million - $1.23 Million	-9,839 Reduced 9.7%	91,610 $10.6 Million
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $165,001 - $194,396	-1,516 Reduced 1.47%	101,449 $12.2 Million
Q4 2020 Feb 02, 2021	SELL	$105.0 - $114.42 $8,295 - $9,039	-79 Reduced 0.08%	102,965 $11.3 Million
Q3 2020 Nov 03, 2020	SELL	$91.64 - $111.29 $64,789 - $78,682	-707 Reduced 0.68%	103,044 $11.2 Million
Q2 2020 Aug 05, 2020	BUY	$76.57 - $98.0 $382,773 - $489,902	4,999 Added 5.06%	103,751 $9.49 Million
Q1 2020 May 06, 2020	SELL	$62.82 - $91.86 $86,817 - $126,950	-1,382 Reduced 1.38%	98,752 $7.79 Million
Q4 2019 Feb 07, 2020	SELL	$78.51 - $87.4 $64,613 - $71,930	-823 Reduced 0.82%	100,134 $8.7 Million
Q3 2019 Oct 31, 2019	SELL	$81.84 - $88.74 $38,792 - $42,062	-474 Reduced 0.47%	100,957 $8.45 Million
Q2 2019 Jul 29, 2019	SELL	$72.88 - $85.0 $487,567 - $568,650	-6,690 Reduced 6.19%	101,431 $8.53 Million
Q1 2019 Apr 30, 2019	SELL	$66.22 - $80.06 $18,144 - $21,936	-274 Reduced 0.25%	108,121 $8.64 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $21,372 - $24,212	-326 Reduced 0.3%	108,395 $7.84 Million
Q3 2018 Nov 02, 2018	SELL	$60.81 - $73.36 $9,851 - $11,884	-162 Reduced 0.15%	108,721 $7.98 Million
Q2 2018 Jul 26, 2018	BUY	$57.57 - $63.54 $28,266 - $31,198	491 Added 0.45%	108,883 $6.64 Million
Q1 2018 May 02, 2018	SELL	$56.27 - $63.62 $10,972 - $12,405	-195 Reduced 0.18%	108,392 $6.5 Million
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $116,807 - $125,054	-2,176 Reduced 1.96%	108,587 $6.2 Million
Q3 2017 Nov 07, 2017	SELL	$48.06 - $53.64 $8,506 - $9,494	-177 Reduced 0.16%	110,763 $5.91 Million
Q2 2017 Aug 14, 2017	BUY	N/A	110,940	110,940 $5.39 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashfield Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashfield Capital Partners, LLC with notifications on news.

Account

Ashfield Capital Partners, LLC Abbott Laboratories Transaction History